Examples of Antigenics MA in a sentence
As consideration for Antigenics MA agreeing to supply GSK with QS-21 under this Agreement, GSK shall pay Antigenics MA a transfer price of [**] percent ([**]%) of the Fully Burdened Costs for QS-21 delivered hereunder up to [**], and thereafter GSK shall pay Antigenics MA a transfer price of [**] percent ([**]%) of the Fully Burdened Costs for QS-21 delivered hereunder.
GSK shall reimburse Antigenics MA for Other Costs in accordance with Section 2.3(e) hereof.
MA’s or its Affiliates’ employees (charged at an FTE rate of [**]), and any consultation services or cooperation charged [**], provided by or on behalf of Antigenics MA or its Affiliates in accordance with the Manufacturing Technology Transfer Plan and (ii) direct and indirect material costs.
GSK shall be responsible for any and all such applicable charges incident to the payments to Antigenics MA under this Agreement, other than taxes on Antigenics MA’s income.
Furthermore and in consideration for the FRTN granted to GSK by Agenus under this Agreement, GSK shall pay Agenus a non-refundable, one-time payment in the amount of US$ 9,000,000 within ten (10) Business Days of the Amendment Effective Date, of which U.S. $2,500,000 shall be creditable against future Manufacturing Technology Transfer Royalty payments otherwise owing to Antigenics MA under Section 5.3 of the Amended Manufacturing Agreement.
Such needs are met, where necessary, through appropriate support, referrals to appropriate bodies and accommodation arrangements.
Antigenics MA shall provide GSK with appropriate certificates of insurance from time to time as requested by GSK unless Antigenics MA is self-insured.
Exhibit C Manufacturing Capacity Quarter/year [**] Antigenics MA Q3/2006 [**] [**] Q4/2006 [**] [**] Q1/2007 [**] a [**] Q2/2007 [**] b [**] Q3/2007 [**]b [**] Q4/2007 [**]b* [**] Q1/2008 [**]b* [**] Q2/2008 [**]b* [**] c [**] a [**] can be [**] to [**] with an [**] and [**] from [**] of the [**].
GSK and Antigenics MA shall keep each other informed of any serious adverse reactions, or other significant, unusual or unexpected safety findings related to QS-21 as provided for in Section 5.8 of the License Agreement.
In addition, in the event of early termination of this Agreement, Antigenics MA retains the right but not the obligation to fill any purchase orders for QS-21 that were made by GSK and accepted by Antigenics MA prior to such date, and GSK shall pay Antigenics MA for any QS-21 supplied by Antigenics MA hereunder.